Skip to content

An ASX-listed innovative biotech company supported by an internationally experienced leadership team and world class scientific advisory board, AdAlta Ltd uses novel i-body technology to generate new drugs in settings where traditional antibodies struggle.

Digital Investment Group: Blue Sky strategies
An Australian Public Company with over 300 shareholders, Digital Investment...
ECP Asset Management Chairman & CIO...
At the beginning of his funds management career, Emmanuel “Manny”...
Admedus (ASX:AHZ): The small-cap medical company...
Since taking the helm of Admedus Ltd. in 2017, CEO,...
Luina Bio: Growing impressively
Brisbane-based company Luina Bio, a drug development and contract manufacturing...
Think Childcare (ASX:TNK) CEO & MD Mathew Edwards: Advancing Early Education
Think Childcare Limited (ASX:TNK) is emerging from the recent volatility...
Ventripoint Diagnostics (TSX-V:VPT): diagnosing heart disease faster, safer and more affordably
Toronto-based Ventripoint Diagnostics Ltd. is on the verge of revolutionizing...
Reforming the current dislocation of financial...
Mark Twain once famously quipped “history doesn’t repeat itself, but...
The grey zone: How business influence...
In the late 1930s the business model was primarily vested...
Enabling global research excellence: Reaching out...
Research and Development is big business. Global spending on R&D...
Artificial Intelligence (AI) and its effect on search engine optimisation (SEO): What you need to know
As with almost all developing technologies, Artificial Intelligence (AI) is...
I’ve just been appointed to the board, what now?
At the Future Directors Institute, we help next generation leaders...
Trust issues? It might be time to embrace the power of PR
Trust is an elusive thing. Faith in an organisation can...

Subscribe FOR FREE TODAY

Receive each quarterly edition of Boardroom Broadcasts for free by signing up to our email newsletter.